ANDA 211582

ZYDUS PHARMS USA INC

FDA Drug Application

Application #211582

Documents

• Letter: 2020-12-07

Application Sponsors

ANDA 211582

ZYDUS PHARMS USA INC

Marketing Status

• None (Tentative Approval): 001
• Prescription: 002

Application Products

001	TABLET;ORAL	5MG	0	DAPAGLIFLOZIN	DAPAGLIFLOZIN
002	TABLET;ORAL	10MG	0	DAPAGLIFLOZIN	DAPAGLIFLOZIN

FDA Submissions

UNKNOWN;

ORIG

1

TA

2020-10-28

STANDARD

Submissions Property Types

ORIG

1

Null

31

TE Codes

001	Prescription	AB
002	Prescription	AB

CDER Filings

ZYDUS PHARMS USA INC

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211582
            [companyName] => ZYDUS PHARMS USA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"DAPAGLIFLOZIN","activeIngredients":"DAPAGLIFLOZIN","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/28\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-10-28
        )

)